486
Views
67
CrossRef citations to date
0
Altmetric
Research Article

Comparative study of poly (lactic-co-glycolic acid)-poly ethyleneimine-plasmid DNA microparticles prepared using double emulsion methods

, &
Pages 1-12 | Received 18 May 2007, Accepted 03 Sep 2007, Published online: 08 Oct 2008

References

  • Abbas AO, Donovan MD, Salem AK. Formulating PLGA particles for plasmid DNA delivery. 2007, Journal of Pharmaceutical Sciences; DOI: 10.1002/jps.21215.
  • Ando S, Putnam D, Pack DW, Langer R. PLGA microspheres containing plasmid DNA: Preservation of supercoiled DNA via cryopreparation and carbohydrate stabilization. Journal of Pharmaceutical Science 1999; 88: 126–130
  • Bivas-Benita M, Romeijn S, Junginger HE, Borchard G. PLGA-PEI nanoparticles for gene delivery to pulmonary epithelium. European Journal of Pharmaceutics and Biopharmaceutics 2004; 58: 1–6
  • Boussif O, Lezoualch F, Zanta MA, Mergny MD, Scherman D, Demeneix B, Behr JP. A versatile vector for gene and oligonucleotide transfer into cells in culture and in-vivo—polyethylenimine. Proceedings of the National Academy of Sciences (USA) 1995; 92(16)7297–7301
  • Capan Y, Woo BH, Gebrekidan S, Ahmed S, DeLuca PP. Influence of formulation parameters on the characteristics of poly(D,L-lactide-co-glycolide) microspheres containing poly(L-lysine) complexed plasmid DNA. Journal of Controlled Release 1999a; 60: 279–286
  • Capan Y, Woo BH, Gebrekidan S, Ahmed S, DeLuca PP. Preparation and characterization of poly (D,L-lactide-co-glycolide) microspheres for controlled release of poly(L-lysine) complexed plasmid DNA. Pharmaceutical Research 1999b; 16: 509–513
  • Capan Y, Woo BH, Gebrekidan S, Ahmed S, DeLuca PP. Stability of poly(L-lysine)-complexed plasmid DNA during mechanical stress and DNase I treatment. Pharmaceutical Development and Technology 1999c; 4: 491–498
  • De Rosa G, Bochot A, Quaglia F, Besnard M, Fattal E. A new delivery system for antisense therapy: PLGA microspheres encapsulating oligonucleotide/polyethyleneimine solid complexes. International Journal of Pharmaceutics 2003; 254: 89–93
  • De Smedt SC, Demeester J, Hennink WE. Cationic polymer based gene delivery systems. Pharmaceutical Research 2000; 17: 113–126
  • dos Santos ALG, Bochot A, Doyle A, Tsapis N, Siepmann J, Siepmann F, Schmaler J, Besnard M, Behar Cohen F, Fattal E. Sustained release of nanosized complexes of polyethylenimine and anti-TGF-beta 2 oligonucleotide improves the outcome of glaucoma surgery. Journal of Controlled Release 2006; 112(3)369–381
  • Eldridge JH, Staas JK, Meulbroek JA, Tice TR, Gilley RM. Biodegradable and biocompatible poly(Dl-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin-B toxoid which enhances the level of toxin-neutralizing antibodies. Infection and Immunity 1991; 59: 2978–2986
  • Gebrekidan S, Woo BH, DeLuca PP. Formulation and in vitro transfection efficiency of poly (D,L-lactide-co-glycolide) microspheres containing plasmid DNA for gene delivery. 2000, AAPS PharmSciTech 1:E28
  • Hanes J, Cleland JL, Langer R. New advances in microsphere-based single-dose vaccines. Advanced Drug Delivery Reviews 1997; 28: 97–119
  • Hsu YY, Hao T, Hedley ML. Comparison of process parameters for microencapsulation of plasmid DNA in poly(D,L-lactic-co-glycolic) acid microspheres. Journal of Drug Targeting 1999; 7: 313–323
  • Huang YC, Simmons C, Kaigler D, Rice KG, Mooney DJ. Bone regeneration in a rat cranial defect with delivery of PEI-condensed plasmid DNA encoding for bone morphogenetic protein-4 (BMP-4). Gene Therapy 2005; 12: 418–426
  • Hung CF, Cheng WF, Hsu KF, Chai CY, He LM, Ling M, Wu TC. Cancer immunotherapy using a DNA vaccine encoding the translocation domain of a bacterial toxin linked to a tumor antigen. Cancer Research 2001; 61(9)3698–3703
  • Kasturi SP, Qin H, Thomson KS, El-Bereir S, Cha SC, Neelapu S, Kwak LW, Roy K. Prophylactic anti-tumor effects in a B cell lymphoma model with DNA vaccines delivered on polyethylenimine (PEI) functionalized PLGA microparticles. Journal of Controlled Release 2006; 113(3)261–270
  • Kasturi SP, Sachaphibulkij K, Roy K. Covalent conjugation of polyethyleneimine on biodegradable microparticles for delivery of plasmid DNA vaccines. Biomaterials 2005; 26: 6375–6385
  • Luo D, Saltzman WM. Synthetic DNA delivery systems. Nature. Biotechnology 2000; 18: 33–37
  • Manuel WS, Zheng J, Hornsby PJ. Transfection by polyethyleneimine-coated microspheres. Journal of Drug Targeting 2001; 9: 15
  • Moffatt S, Cristiano RJ. Uptake characteristics of NGR-coupled stealth PEI/pDNA nanoparticles loaded with PLGA-PEG-PLGA tri-block copolymer for targeted delivery to human monocyte-derived dendritic cells. International Journal of Pharmaceutics 2006a; 321: 143–154
  • Moffatt S, Cristiano RJ. PEGylated J591 mAb loaded in PLGA-PEG-PLGA tri-block copolymer for targeted delivery: in vitro evaluation in human prostate cancer cells. International Journal of Pharmaceutics 2006b; 317: 10–13
  • Nam YS, Kang HS, Park JY, Park TG, Han SH, Chang IS. New micelle-like polymer aggregates made from PEI-PLGA diblock copolymers: Micellar characteristics and cellular uptake. Biomaterials 2003; 24: 2053–2059
  • O'hagan DT, Singh M, Ulmer JB. Microparticles for the delivery of DNA vaccines. Immunological Reviews 2004; 199: 191–200
  • Oster CG, Kim N, Grode L, Barbu-Tudoran L, Schaper AK, Kaufmann SHE, Kissel T. Cationic microparticles consisting of poly(lactide-co-glycolide) and polyethylenimine as carriers systems for parental DNA vaccination. Journal of Controlled Release 2005; 104(2)359–377
  • Oster CG, Kissel T. Comparative study of DNA encapsulation into PLGA microparticles using modified double emulsion methods and spray drying techniques. Journal of Microencapsulation 2005; 22: 235–244
  • Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Advanced Drug Delivery Reviews 2003; 55: 329–347
  • Pouton CW, Seymour LW. Key issues in non-viral gene delivery. Advanced Drug Delivery Reviews 2001; 46: 187–203
  • Prabha S, Labhasetwar V. Critical determinants in PLGA/PLA nanoparticle-mediated gene expression. Pharmaceutical Research 2004; 21: 354–364
  • Ravi Kumar MN, Bakowsky U, Lehr CM. Preparation and characterization of cationic PLGA nanospheres as DNA carriers. Biomaterials 2004; 25: 1771–1777
  • Roy K, Mao HQ, Huang SK, Leong KW. Oral gene delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nature Medicine 1999; 5: 387–391
  • Salem AK, Hung CF, Kim TW, Wu TC, Searson PC, Leong KW. Multi-component nanorods for vaccination applications. Nanotechnology 2005; 16: 484–487
  • Salem AK, Searson PC, Leong KW. Multifunctional nanorods for gene delivery. Nature Materials 2003; 2: 668–671
  • Singh M, Briones M, Ott G, O'hagan D. Cationic microparticles: A potent delivery system for DNA vaccines. Proceedings of the National Academy of Sciences (USA) 2000; 97: 811–816
  • Singh M, Ugozzoli M, Briones M, Kazzaz J, Soenawan E, O'hagan DT. The effect of CTAB concentration in cationic PLG microparticles on DNA adsorption and in vivo performance. Pharmaceutical Research 2003; 20: 247–251
  • Sutton D, Durand R, Shuai XT, Gao JM. Poly(D,L-lactide-co-glycolide)/poly(ethylenimine) blend matrix system for pH sensitive drug delivery. Journal of Applied Polymer Science 2006; 100: 89–96
  • Tang DC, Devit M, Johnston SA. Genetic immunization is a simple method for eliciting an immune-response. Nature 1992; 356: 152–154
  • Tinsley-Bown AM, Fretwell R, Dowsett AB, Davis SL, Farrar GH. Formulation of poly(D,L-lactic-co-glycolic acid) microparticles for rapid plasmid DNA delivery. Journal of Controlled Release 2000; 66: 229–241
  • Ungaro F, De Rosa G, Quaglia F, Fattal E, La Rotonda MI. Controlled release of oligonucleotide/polyethyleneimine complexes from PLGA-based microspheres: Potential of spray-drying technique. Journal of Drug Delivery Science and Technology 2005; 15: 137–143
  • Walter E, Dreher D, Kok M, Thiele L, Kiama SG, Gehr P, Merkle HP. Hydrophilic poly(Dl-lactide-co-glycolide) microspheres for the delivery of DNA to human-derived macrophages and dendritic cells. Journal of Controlled Release 2001; 76(1–2)149–168
  • Walter E, Merkle HP. Microparticle-mediated transfection of non-phagocytic cells in vitro. Journal of Drug Targeting 2002; 10: 11–21
  • Walter E, Moelling K, Pavlovic J, Merkle HP. Microencapsulation of DNA using poly(Dl-lactide-co-glycolide): Stability issues and release characteristics. Journal of Controlled Release 1999; 61: 361–374
  • Wasan EK, Reimer DL, Bally MB. Plasmid DNA is protected against ultrasonic cavitation-induced damage when complexed to cationic liposomes. Journal of Pharmaceutical Science 1996; 85: 427–433
  • Zhang XQ, Dahle CE, Baman NK, Rich N, Weiner GJ, Salem AK. Potent antigen-specific immune responses stimulated by co-delivery of CpG ODN and antigens in degradable microparticles. Journal of Immunotherapy 2007a; 30: 469–478
  • Zhang XQ, Dahle CE, Weiner GJ, Salem AK. A comparative study of the antigen-specific immune response induced by co-delivery of CpG ODN and antigen using fusion molecules or biodegradable microparticles. 2007b, Journal of Pharmaceutical Sciences. DOI, 10.1002/jps.20978
  • Zhang XQ, Intra J, Salem AK. Conjugation of polyamidoamine dendrimers on biodegradable microparticles for non-viral gene delivery. 10. 2007c, Bioconjugate Chemistry. DOI, 1021/bc070116l

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.